Factors predicting the use of immunotherapy for patients with advanced melanoma.

被引：0
|
作者：
Joseph, Richard Wayne
Shillington, Alicia
Macahilig, Cynthia
Diede, Scott J.
Dave, Vaidehi
Harshaw, Qing
Liu, Frank Xiaoqing
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] EPI Q Inc, Oak Brook, IL USA
[3] Med Data Analyt, Parsippany, NJ USA
[4] Merck Co Inc, Kenilworth, NJ USA
[5] Merck & Co Inc, North Wales, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9571
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A novel immunotherapy for advanced melanoma.
    Wang, X
    Chen, HY
    Lin, JR
    Xie, B
    Wu, L
    Yang, DM
    [J]. CLINICAL IMMUNOLOGY, 2002, 103 (03) : S72 - S73
  • [2] A proteomic biomarker discovery platform for predicting clinical benefit of immunotherapy in advanced melanoma.
    Shaked, Yuval
    Harel, Michal
    Issler, Eran
    Fremder, Ella
    Jacob, Eyal
    Dahan, Nili
    Bar, Haim
    Halaban, Ruth
    Sznol, Mario
    Sharon, Ofer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Factors associated with immunotherapy selection in patients with advanced melanoma
    Joseph, Richard W.
    Shillington, Alicia C.
    Macahilig, Cynthia
    Diede, Scott J.
    Dave, Vaidehi
    Harshaw, Qing
    Liu, Frank Xiaoqing
    [J]. IMMUNOTHERAPY, 2018, 10 (16) : 1361 - 1369
  • [4] Comparison of PET-based criteria of evaluation of response to immunotherapy in patients with advanced melanoma.
    Comito, Francesca
    Pagani, Rachele
    Aprile, Marta
    Dragonetti, Valentino
    Bonazzi, Norma
    Battisti, Giacomo
    Malizia, Claudio
    Nanni, Cristina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Using machine learning to predict immunotherapy response in advanced melanoma.
    Johannet, Paul
    Coudray, Nicolas
    Donnelly, Douglas M.
    Jour, George
    Illa-Bochaca, Irineu
    Xia, Yuhe
    Johnson, Douglas Buckner
    Wheless, Lee E.
    Patrinely, James Randall
    Pavlick, Anna C.
    Weber, Jeffrey S.
    Zhong, Hua
    Tsirigos, Aristotelis
    Osmannyu, Iman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Correlation between homologous recombination repair gene mutation and immunotherapy efficacy in patients with advanced melanoma.
    You, Changxuan
    Zhou, Chengzhi
    You, Zhixuan
    Lv, Meng
    He, Xuanyu
    Pan, Yingqin
    Ge, Junfeng
    Hu, Xue
    Zheng, Yating
    Huang, Mengli
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Immunotherapy disparities in metastatic melanoma.
    Oliver, Thomas
    Pezzi, Todd A.
    Pezzi, Ashley E.
    Shreders, Amanda
    Dao, Henry
    Crozier, Jennifer A.
    Pezzi, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Knowledge about risks, benefits, and curative potential of immunotherapy among patients with advanced lung cancer or melanoma.
    Petrillo, Laura A.
    Zhou, Ashley
    Sullivan, Ryan J.
    Volandes, Angelo E.
    Greer, Joseph A.
    Temel, Jennifer S.
    El-Jawahri, Areej
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] A phase I study of neoadjuvant combination immunotherapy in locally/regionally advanced melanoma.
    Najjar, Yana
    McCurry, Dustin
    Lin, Huang
    Lin, Yan
    Davar, Diwakar
    Drabick, Joseph J.
    Neves, Rogerio Izar
    Ernstoff, Marc S.
    Puzanov, Igor
    Skitzki, Joseph J.
    Pingpank, James F.
    Holtzman, Matthew Peter
    Sander, Cindy
    Rose, Amy
    Kirkwood, John M.
    Tarhini, Ahmad A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Multiple primary malignancies among patients with advanced melanoma.
    Ebia, Matthew Isaiah
    In, Gino Kim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345